B2B Sales Methodology, Deal Qualification, and Sales Training3 min readUpdated September 2026

Underwriting the Sale: MEDDIC vs Challenger for ABL Lenders

A specialty asset-based lender is usually competing against two very different alternatives at once: a traditional bank offering a lower rate with tighter covenants, and another specialty lender offering similar flexibility at a similar price. Qualifying which competitor you are actually up against, before you price the facility, changes both your pitch and your terms.

Vendors Covered in this Article

Disclosure: We may earn a commission if you buy through some links on this page. It doesn't change what we recommend.

What MEDDIC Gets Right for Borrower Qualification

MEDDIC's strength is forcing clarity on Decision Criteria before you underwrite: is this borrower's treasurer or CFO optimizing for the lowest all-in rate, maximum advance rate against collateral, covenant flexibility, or speed of close because they are under a liquidity deadline. A facility priced and structured without knowing which of these actually matters most to the borrower often loses to a competitor who asked the right question first.

MEDDIC is weaker at winning a borrower who assumes, often correctly, that a bank will always be cheaper and has not yet considered why covenant flexibility or advance rate might matter more than rate alone.

What Challenger Gets Right for the Same Borrower

A Challenger-style conversation works well against the assumption that a bank is automatically the better option. Bringing a specific, credible point about how a bank's tighter covenant package or lower advance rate actually constrains this borrower's growth or working capital flexibility, tailored to their actual balance sheet, reframes the comparison away from headline rate toward total capital efficiency.

Challenger is weaker once the borrower is convinced and ready to move: at that point they need MEDDIC discipline to confirm who signs the credit agreement and what the underwriting Decision Process actually requires, not another round of persuasion.

Combining Both for a Rate-Sensitive Environment

Open with a Challenger-style reframe when a borrower's first instinct is to assume a bank is cheaper and better by default. Once they are engaged, switch to MEDDIC: confirm the actual Economic Buyer (a borrower's treasurer often runs the process, but a board or a PE sponsor backing the company may need to approve terms above a certain facility size), name the true Decision Criteria, and identify who internally will defend choosing a specialty lender over a bank when someone questions the rate difference later.

Facility pricing itself is sensitive to where the 10-year Treasury yield and broader rate environment sit, and a lending team that tracks this closely can have a more credible, timely conversation with a borrower about why their spread looks the way it does right now1.

Work a rate-sensitive borrower conversation in this sequence:

  1. Open with a Challenger-style reframe when the borrower assumes a bank is automatically cheaper and better.
  2. Once the borrower is engaged, confirm the Economic Buyer, remembering that a treasurer may run the process while a board or PE sponsor approves larger facilities.
  3. Name the true Decision Criteria: lowest all-in rate, maximum advance rate, covenant flexibility, or speed of close.
  4. Qualify for urgency early, since a borrower facing a liquidity deadline cares mostly about speed and certainty of funding.

Where the Comparison Breaks Down: Distressed or Time-Pressured Borrowers

None of the above applies cleanly to a borrower facing a genuine liquidity crunch on a tight timeline. In that situation, speed of close and certainty of funding dominate every other decision criteria, and a Challenger-style reframe about long-term capital efficiency reads as tone-deaf to someone who needs funding within weeks. Qualify for urgency directly and early: a borrower under real time pressure needs a fast, clear underwriting timeline more than a persuasive pitch about flexibility.

Tracking Win Rate Against Bank Alternatives Specifically

Tag every won and lost deal by whether the primary competing alternative was a bank, another specialty lender, or no external financing at all, and review win rate by competitor type separately. Lending teams often assume they win or lose deals for the same reasons across the board, when in practice the reframe that beats a bank rarely resembles the argument that beats another specialty lender on terms.

Qualifying Renewal and Upsize Requests Differently From New Borrowers

A borrower coming back for a facility renewal or an upsize as their business grows is not the same qualification conversation as a brand-new relationship. Trust is already established, and the real question shifts to whether the collateral base and covenant structure still fit the business as it exists today, not whether the borrower is a fit for the lender at all. Use the renewal conversation to confirm the borrower's decision criteria have not shifted, a growing borrower's treasurer may suddenly care more about facility size and speed of draw than the rate sensitivity that mattered at origination.

A lending team that runs the same new-borrower pitch at renewal misses this shift entirely, and risks losing an upsize opportunity to a competitor who asked what actually changed in the borrower's business since the facility was first underwritten.

Build a standing check-in into every active facility, not just a renewal-window outreach, so a growing borrower's changing needs surface before they start shopping a competing lender out of frustration with a facility that no longer fits their business.

Executive Capability Standard

What Good Looks Like

A disciplined ABL sales process identifies which competitor, a bank or another specialty lender, is actually in play before pricing a facility, and adjusts between a Challenger-style reframe and a speed-focused pitch based on the borrower's real urgency.

Building The Capability (5-Stage Skill Ladder)

1. Learn:Review your last several closed and lost deals and tag each by primary competing alternative: bank, another specialty lender, or none.
2. Do Manually:Add a standard qualifying question to every borrower intake call asking what alternative financing they are actively comparing.
3. Delegate:Assign a credit or capital markets analyst to track rate environment context so lending officers can speak to current spread conditions credibly.
4. Automate:Use Gong to review borrower calls for whether decision criteria and the competing alternative were confirmed before terms were proposed.
5. Buy:Track deals in Salesforce tagged by competing alternative and urgency level so win-rate patterns are visible by competitor type.

How to Get Started

Disclosure: We may earn a commission if you buy through some links on this page. It doesn't change what we recommend.

Frequently Asked Questions

How do we compete against a bank offering a lower headline rate?

Reframe the comparison away from rate alone toward total capital efficiency: advance rate against collateral, covenant flexibility, and speed of close. A specific, credible point about how a bank's tighter structure would actually constrain this borrower's working capital or growth plans works better than arguing rate directly.

Who typically approves an asset-based lending facility beyond the borrower's treasurer?

For a PE-backed borrower or one operating under board oversight, approval above a certain facility size often requires sponsor or board sign-off, not just the treasurer or CFO running day-to-day discussions. Confirm this early so pricing and terms are built for the actual approver, not just the primary contact.

Should we pitch flexibility to every prospective borrower the same way?

No. A borrower facing a genuine liquidity crunch on a tight timeline cares primarily about speed and certainty of funding, and a long-term capital efficiency pitch will read as unresponsive to their actual situation. Qualify for urgency early and adjust the conversation accordingly.

Sources

Where we quote a benchmark, we show its source. Other figures in this guide are estimates or general guidance, so check them against your own numbers.

  1. 10-year US Treasury constant-maturity yield. Federal Reserve H.15 Selected Interest Rates, 2026.

Related Guides